Evidence map›Paper›PMID 33155979›Full record

ArticleeLife2020

Arrayed CRISPRi and quantitative imaging describe the morphotypic landscape of essential mycobacterial genes.

Timothy J de Wet, Kristy R Winkler, Musa Mhlanga, Valerie Mizrahi, Digby F Warner

Abstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Article
  2. Article
  3. AssessingbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Analysis of essential genes inJournal of bacteriology · 2025
    Article
  7. Article
  8. Article
  9. Analysis of Essential Genes inbioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Leveraging EngineeredACS synthetic biology · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Timothy J de WetSAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department of Pathology, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-3978-5322
Kristy R WinklerSAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department of Pathology, University of Cape Town, Cape Town, South Africa.ORCID 0000-0003-3098-3290
Musa MhlangaInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Valerie MizrahiSAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department of Pathology, University of Cape Town, Cape Town, South Africa.ORCID 0000-0003-4824-9115
Digby F WarnerSAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department of Pathology, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-4146-0930

Funding

Replisome dynamics in M tuberculosis_linking persistence to genetic resistanceU01HD085531 · NICHD · UNIVERSITY OF CAPE TOWN · PI WARNER, DIGBY FRANCIS, WOODGATE, ROGER · 2015 to 2019
$1.1M
NICHD NIH HHS U01 HD085531Norges Forskningsråd 261669Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsCRISPR-Cas SystemsDrug Resistance, BacterialGene Knockdown TechniquesGene LibraryGenes, BacterialGenome, BacterialImage Processing, Computer-AssistedMetabolic Networks and PathwaysMultigene FamilyMycobacterium smegmatisMycobacterium tuberculosisMycolic AcidsAnti-Bacterial AgentsMycolic AcidsCRISPRifunctional genomicsgeneticsgenomicsinfectious diseasemicrobiologyMycobacterium smegmatisMycobacterium tuberculosisphenoprintUMAP

Identifiers

PMID33155979
PMCPMC7647400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.